|
gptkbp:instanceOf
|
biotechnology company
|
|
gptkbp:acquisition
|
gptkb:Semma_Therapeutics
Exonics Therapeutics
|
|
gptkbp:advertising
|
gptkb:Michael_A._Haller
gptkb:Ira_C._Shapiro
|
|
gptkbp:awards
|
Best Places to Work
Best Workplaces for Parents
Best Workplaces for Diversity
Best Workplaces for Women
Top_100_Global_Innovators
|
|
gptkbp:CEO
|
Reshma Kewalramani
|
|
gptkbp:clinicalTrials
|
Phase 3 trials for cystic fibrosis
multiple therapies for cystic fibrosis
therapies for beta-thalassemia
therapies for pain
therapies for sickle cell disease
therapies for type 1 diabetes
|
|
gptkbp:collaborations
|
gptkb:Harvard_University
gptkb:Massachusetts_Institute_of_Technology
gptkb:University_of_Pennsylvania
|
|
gptkbp:community_engagement
|
support for cystic fibrosis community
|
|
gptkbp:employeeCount
|
approximately 2,000
|
|
gptkbp:focus
|
cystic fibrosis
|
|
gptkbp:founded
|
1989
|
|
gptkbp:founder
|
gptkb:Joshua_Boger
|
|
gptkbp:headquarters
|
gptkb:Boston,_Massachusetts
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Vertex Pharmaceuticals
|
|
gptkbp:investmentFocus
|
in research and development
in community health initiatives
in educational programs for healthcare professionals
in environmental sustainability initiatives
in patient access programs
|
|
gptkbp:leadership
|
diverse executive team
|
|
gptkbp:market
|
$50 billion (2021)
|
|
gptkbp:partnerships
|
gptkb:Moderna
gptkb:CRISPR_Therapeutics
|
|
gptkbp:patentCitation
|
over 1,000 patents
|
|
gptkbp:philanthropy
|
gptkb:Vertex_Foundation
|
|
gptkbp:products
|
Kalydeco
Orkambi
Symdeko
Trikafta
|
|
gptkbp:regulates
|
gptkb:Kathy_H._Hsu
|
|
gptkbp:research
|
gptkb:David_Altshuler
|
|
gptkbp:research_focus
|
gene editing
small molecule drugs
|
|
gptkbp:revenue
|
$3.4 billion (2020)
|
|
gptkbp:stockExchange
|
gptkb:NASDAQ
VRTX
|
|
gptkbp:subsidiary
|
gptkb:Vertex_Pharmaceuticals_(Singapore)_Pte._Ltd.
gptkb:Vertex_Pharmaceuticals_(Japan)_K.K.
gptkb:Vertex_Pharmaceuticals_(Australia)_Pty_Ltd.
gptkb:Vertex_Pharmaceuticals_(Canada)_Inc.
gptkb:Vertex_Pharmaceuticals_(Europe)_Limited
|